VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells.
Immunotherapy of metastatic melanoma using genetically engineered GD2-specific T cells. Clin Cancer Res. 2009 Sep 15; 15(18):5852-60.
View in:
PubMed
subject areas
Animals
Antibodies
Gangliosides
Genetic Engineering
Humans
Immunotherapy
Melanoma
Mice
Mice, SCID
Neoplasm Metastasis
Receptors, Antigen, T-Cell
T-Lymphocytes
Xenograft Model Antitumor Assays
authors with profiles
VALENTINA HOYOS
MALCOLM BRENNER